RESUMEN
Background: During clinical practice, it has been observed that cases of sigmoid volvulus can develop complications post-treatment corresponding to acute colonic pseudo-obstruction (ACPO) and chronic intestinal pseudo-obstruction (CIPO), with the acute form, also known as Ogilvie's syndrome, being more common. The cause and underlying mechanism for the development of these conditions are not fully understood. Although potential causes have been described in other studies, research focused on the status of ganglion cells and the patient's microbiome is limited. This study aims to contribute to the medical literature by examining the ganglion cell content and microbial diversity in six patients diagnosed with acute and chronic colonic pseudo-obstruction observed in patients from the high Andean region of southern Peru. Case Presentation: The common background characterizing and grouping the reported cases is the previous sigmoidectomy for sigmoid volvulus, along with the presence of signs and symptoms of an acute and chronic functional obstructive condition. In all cases, the clinical diagnosis following the treatment of sigmoid volvulus was ACPO or CIPO. These diagnoses were confirmed by abdominal X-ray and tomography. A conservative medical treatment with Neostigmine was initiated. The lack of response to this treatment led to various surgical techniques being performed. Conclusion: All patients presented with hypoganglionosis. According to microbiome analysis, in four of them, the predominant phylum was Firmicutes and the predominant enterotype was Prevotella. In the other two patients, a high percentage of Proteobacteria was observed, with Bacteroides as the predominant enterotype. The average Firmicutes/Bacteroidetes ratio was 4.9. Our study shows the existence of bacterial dysbiosis in two patients with colonic hypoganglionosis, which could be related to the pathophysiology of ACPO and CIPO. Additionally, we report alterations in the relative frequency of bacteria associated with flavonoid metabolism.
Antecedentes: Durante la práctica clínica se ha observado que los casos de vólvulo sigmoideo pueden tener complicaciones posteriores a su tratamiento correspondientes al síndrome de pseudoobstrucción colónica aguda (ACPO, por sus siglas en inglés) y crónica (CIPO, por sus siglas en inglés), siendo mucho más frecuente su forma aguda también llamado síndrome de Ogilvie. No se comprende completamente la causa y el mecanismo subyacente al desarrollo de estas condiciones. Aunque se han descrito posibles causas en otros estudios, la investigación enfocada en el estado de las células ganglionares y el microbioma del paciente es limitada. Este estudio tiene como objetivo aportar a la literatura médica el conteo de las células ganglionares y la diversidad microbiana de seis pacientes diagnosticados con pseudoobstrucción colónica aguda y crónica observada en pacientes de la zona altoandina del sur del Perú. Presentación de caso: El antecedente común que caracteriza y agrupa a los casos reportados es la sigmoidectomía previa por vólvulo de sigmoides, junto con la presencia de signos y síntomas de un cuadro obstructivo funcional agudo y crónico. En todos los casos, el diagnóstico clínico posterior al tratamiento de vólvulo sigmoideo fue ACPO o CIPO. Estos diagnósticos fueron confirmados mediante radiografía de abdomen y tomografía. Se inició un tratamiento médico conservador con Neostigmina. La falta de respuesta al tratamiento conllevó a realizar diversas técnicas quirúrgicas. Conclusión: Todos los pacientes mostraron hipoganglionosis. Según el análisis del microbioma, en cuatro de ellos, el filo predominante fue Firmicutes y el enterotipo predominante fue Prevotella. En los otros dos pacientes, se observó un porcentaje elevado de Proteobacterias, con Bacteroides como enterotipo predominante. La relación de Firmicutes/Bacteroidetes promedio fue de 4.9. Nuestro estudio muestra la existencia de disbiosis bacteriana en dos pacientes con hipoganglionosis colónica, que podría estar relacionada con la fisiopatología del ACPO y del CIPO. Adicionalmente, reportamos alteraciones en la frecuencia relativa de bacterias asociadas al metabolismo de flavonoides.
RESUMEN
Despite the species' wide distribution, studies of the genetic diversity within Entamoeba coli and Entamoeba hartmanni remain limited. In the present study, we provide further insight into the genetic diversity of both species based on analysis of partial nuclear small subunit ribosomal DNA sequences generated from human fecal DNAs from samples collected in Africa, South America, and Europe. Reinforcing the previous recognition that E. coli is a species complex, our data confirm the existence of the two subtypes, ST1 and ST2, previously identified plus, potentially, a new subtype, ST3. While ST1 appears to be genetically quite homogenous, ST2 shows a substantial degree of intrasubtype diversity. ST2 was more common in samples collected outside Europe, whereas ST1 showed no geographical restriction. The potentially novel subtype is represented to date exclusively by sequences from South American and African samples. In contrast to previous reports, our new data also indicate substantial variation in E. hartmanni that could also support the establishment of subtypes within this species. Here, however, no links were identified between subtype and geographical origin.
Asunto(s)
Blastocystis , Entamoeba , Humanos , Entamoeba/genética , Escherichia coli , Proteína 1 Similar al Receptor de Interleucina-1/genética , ADN Ribosómico/genética , Heces , Filogenia , Variación Genética , Blastocystis/genéticaRESUMEN
Blastocystis is one of the most common protozoa found in the human gut and are genetically diverse and widely distributed around the world. Nonspecific and inconsistent symptoms have been associated with this protozoon; thus, its clinical importance remains controversial. Our aim was to estimate the relative frequency of Blastocystis subtypes 1, 2, and 3, which are the predominant subtypes reported in South America, based on conserved regions of SSU rDNA sequences and determine the factors associated with them. A total of 116 Blastocystis-positive stool samples were processed using conventional PCR with Blastocystis-specific primers. We identified subtype 1 (10.3%), subtype 2 (7.8%), subtype 3 (25.0%), and mixed subtype infections (8.7%). However, we could not identify any Blastocystis subtypes in 48.3% of the samples; therefore, it is likely that other subtypes were present in the area. No association was found between any gastrointestinal symptom and single or mixed Blastocystis subtypes. We found a statistically significant association between Blastocystis subtype 2 and irritable bowel syndrome (OR = 17.8, 95% CI = 1.5-408.4, p = 0.039); however, the number of samples with IBS was small (n= 4). There was no association between the Blastocystis subtypes and any epidemiological variable studied. In rural populations, we only identified subtype 1, while in urban and periurban populations, we identified subtypes 1, 2, and 3.
RESUMEN
Blastocystis is one of the most common protozoa in the human gut and a zoonotic organism related to unsanitary living conditions. This protozoon shows a broad distribution, unclear symptomatology, and undefined pathogenicity. In Peru, studies report the presence of Blastocystis in many regions, but the highest prevalence levels are reported in Arequipa. The aim of this study was to link Blastocystis infection with social determinants of health. We recruited and surveyed 232 infected and uninfected participants from houses with at least one Blastocystis-infected person. All samples were concentrated by spin concentration method in saline solution, examined by wet mount under light microscopy and confirmed with methylene-stained stool smear. We found a human Blastocystis prevalence of 51.3% in the study sample. We also found statistical associations between Blastocystis infection and peri-urban location in the city as well as the use of alternative non-domiciliary water supplies, suggesting these are risk factors for human Blastocystis infection.